Medical specialists from Canada tagged as investigators in clinical trials studying Neoplasm Metastasis
Total 141 results
-
Jean-François Berthin Ouellet, MDSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT06349278 (Sub-Investigator)
Conditions: -
Jean-François Boileau, MD,MSc,FRCSCSeen in:
- Quebec, Montreal, Jewish General Hospital
Trials:- NCT04671511 (Principal Investigator)
-
Jean-François Ouellet, MDSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT06349278 (Sub-Investigator)
Conditions: -
Jean-François Tremblay, MDSeen in:
- Quebec, Montréal, CIUSSS de l'Est-de-l'Île-de-Montréal
Trials:- NCT05623787 (Sub-Investigator)
- NCT05687617 (Sub-Investigator)
-
Jean-Pierre Gagné, MDSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT05687617 (Sub-Investigator)
-
Jeffrey N Greenspoon, MD FRCPCSeen in:
- Ontario, Hamilton, Juravinski Cancer Centre
Trials:- NCT01353573 (Principal Investigator)
Conditions: -
Jeffrey N. GreenspoonSeen in:
- Ontario, Hamilton, Juravinski Cancer Centre at Hamilton Health Sciences
Trials:- NCT03550391 (Principal Investigator)
- NCT04114981 (Principal Investigator)
-
Joel Werier, MD, FRCSCSeen in:
- Ontario, Ottawa, The Ottawa Hospital
Trials:- NCT03944798 (Principal Investigator)
Conditions: -
John Cho, MDSeen in:
- Ontario, Toronto, Princess Margaret Hospital, University Health Network
Trials:- NCT01803542 (Principal Investigator)
Conditions: -
John Street, MD, PhDSeen in:
- British Columbia, Vancouver, Vancouver General Hospital
Trials:- NCT03632005 (Principal Investigator)
Conditions: -
Jon-Paul Voroney, PHD. M.D.Seen in:
- Alberta, Calgary, Tom Baker Cancer Centre
Trials:- NCT01476878 (Principal Investigator)
Conditions: -
Jose Luiz Miranda GuimaraesSeen in:
- Quebec, Chicoutimi, CIUSSS- saguenay-Lac-Saint-Jean
Trials:- NCT06119581 (Principal Investigator)
Conditions: -
Juan F Asenjo, MDSeen in:
- Quebec, Montreal, Montreal General Hospital
Trials:- NCT00294073 (Principal Investigator)
- NCT00294151 (Principal Investigator)
Conditions: -
Karen Mulder, MDSeen in:
- Alberta, Edmonton, Cross Cancer Institute
Trials:- NCT03678883 (Principal Investigator)
Conditions:- Sarcoma;
- Cancer;
- Breast Neoplasms;
- Neoplasm Metastasis;
- Pancreatic Neoplasms;
- Pancreatic Cancer;
- Pancreatic Adenocarcinoma;
- Bone Cancer;
- Malignant Glioma;
- Bone Metastases;
- Pancreas Cancer;
- Renal Cancer;
- Refractory Non-Hodgkin Lymphoma;
- Bone Neoplasm;
- Neoplasm, Breast;
- Refractory Cancer;
- Refractory Neoplasm;
- Resistant Cancer;
- Neoplasm of Bone;
- Neoplasm of Lung;
- Neoplasms,Colorectal;
- Neoplasms Pancreatic;
- Malignancies;
- Malignancies Multiple;
- Acute T Cell Leukemia Lymphoma
-
Kim Tsoi, MD,FRCSCSeen in:
- Ontario, Toronto, Mount Sinai Hospital
Trials:- NCT03944798 (Sub-Investigator)
Conditions: -
Kurian Joseph, MDSeen in:
- Alberta, Edmonton, Cross Cancer Institute
Trials:- NCT04797299 (Principal Investigator)
- NCT04242589 (Principal Investigator)
Conditions: -
Laura Masucci, MDSeen in:
- Quebec, Montreal, Centre Hospitalier de l'Universite de Montreal
- Quebec, Montreal, Klink, Ruby
- Quebec, Montréal, Véronique Freire
Trials:- NCT05317026 (Sub-Investigator)
- NCT02098252 (Sub-Investigator)
-
Laurent Milot, MDSeen in:
- Ontario, Toronto, Sunnybrook Health Sciences Centre
Trials:- NCT02036008 (Principal Investigator)
Conditions: -
Léamarie Meloche-Dumas, MDSeen in:
- Quebec, Montreal, Centre Hospitalier de l'Universite de Montreal
Trials:- NCT04671511 (Principal Investigator)
-
Liam A. MulroySeen in:
- Nova Scotia, Halifax, QEII Health Sciences Centre/Nova Scotia Health Authority
Trials:- NCT03550391 (Principal Investigator)
Conditions: -
Liam MulroySeen in:
- Nova Scotia, Halifax, Nova Scotia Health Authortiy
Trials:- NCT03721341 (Principal Investigator)
Conditions: -
Livia Florianova, MD,MSc,FRCPCSeen in:
- Quebec, Montreal, Jewish General Hospital
Trials:- NCT04671511 (Sub-Investigator)
-
Lucas Sidéris, MDSeen in:
- Quebec, Montreal, Maisonneuve-Rosemont Hospital
- Quebec, Montréal, CIUSSS de l'Est-de-l'Île-de-Montréal
Trials:- NCT05623787 (Sub-Investigator)
- NCT05687617 (Sub-Investigator)
- NCT00290524 (Sub-Investigator)
-
Lucy GilbertSeen in:
- Quebec, Montreal, McGill University Department of Oncology / McGill University Health Centre
- Quebec, Montreal, McGill University Health Centre
- Quebec, Montréal, McGill University Health Centre
- Quebec, Montréal, McGill University Health Centre (MUHC)
Trials:- NCT05456685 (Principal Investigator)
- NCT05611931 (Principal Investigator)
- NCT02632448 (Principal Investigator)
- NCT06003231 (Principal Investigator)
Conditions:- Fallopian Tube Cancer;
- Primary Peritoneal Cancer;
- High Grade Ovarian Cancer;
- Endometrial Cancer;
- Neoplasms;
- Soft Tissue Sarcoma;
- Breast Cancer;
- Colorectal Cancer;
- Pancreatic Cancer;
- Ovarian Cancer;
- Rectal Cancer;
- Triple Negative Breast Cancer;
- Colon Cancer;
- Solid Tumors;
- Pancreas Cancer;
- Carcinoma, Non-Small-Cell Lung;
- Ovarian Neoplasms;
- Endometrial Neoplasms;
- Carcinoma, Squamous Cell of Head and Neck
-
Marc Isler, MDSeen in:
- Quebec, Montréal, Hopital Maisonneuve-Rosemont
Trials:- NCT03944798 (Sub-Investigator)
Conditions: -
Marcelo Cypel, MDSeen in:
- Ontario, Toronto, University Health Network Princess Margaret Cancer Center P2C
- Ontario, Toronto, University Health Network, Toronto General Hospital
Trials:- NCT03599752 (Principal Investigator)
- NCT05611034 (Principal Investigator)
-
Marco Marra, PhDSeen in:
- British Columbia, Vancouver, BC Cancer Agency
Trials:- NCT02155621 (Principal Investigator)
-
Marcus KochSeen in:
- Alberta, Calgary, Foothills Medical Centre
Trials:- NCT05013463 (Principal Investigator)
Conditions: -
Martin SmoragiewiczSeen in:
- Ontario, Toronto, GSK Investigational Site
- Ontario, Toronto, Sunnybrook Health Sciences Centre
- Ontario, Toronto, Sunnybrook Research Institute
Trials:- NCT05288166 (Principal Investigator)
- NCT06062420 (Principal Investigator)
Conditions:- Urogenital Neoplasms;
- Prostatic Neoplasms;
- Neoplasm Metastasis;
- Enzyme Inhibitors;
- Antineoplastic Agents;
- Hormones;
- Physiological Effects of Drugs;
- Antineoplastic Agents, Hormonal;
- Androgens;
- Hormones, Hormone Substitutes, and Hormone Antagonists;
- Abiraterone Acetate;
- Steroid Synthesis Inhibitors;
- Cytochrome P-450;
- Prednisone;
- Prednisolone;
- Cyclin-Dependent Kinase 4;
- Cyclin-Dependent Kinase 6;
- Neoplasms, Head and Neck
-
Maxime Chénard-Poirier, MDSeen in:
- Quebec, Quebec City, CHU de Québec
Trials:- NCT06349278 (Sub-Investigator)
Conditions:
Clinical Trials on Neoplasm Metastasis
-
Betta Pharmaceuticals Co., Ltd.Recruiting
-
BayerCompleted
-
BayerCompletedNeoplasm Metastasis / Bone and BonesBelgium, Spain, Taiwan, United States, Japan, Russian Federation, Canada, Finland, Korea, Republic of, Singapore, Australia, Germany, Israel, United Kingdom, Italy, France, Poland, Brazil, Czechia, Norway, Sweden, Hong Kong
-
National Cancer Institute (NCI)TerminatedCancer | Neoplasm Metastasis | Metastasis | Neoplasm | Radiation OncologyUnited States
-
MedtronicNeuroCompletedMetastasis Spine | Metastasis to BoneUnited States, Luxembourg, Germany, France, Canada
-
Cho Ray HospitalUniversity of Medicine and Pharmacy at Ho Chi Minh CityRecruitingSynchronous Neoplasm | Liver Metastasis Colon CancerVietnam
-
Assiut UniversityNot yet recruiting
-
Amsterdam UMC, location VUmcRecruiting
-
Synthorx, Inc, a Sanofi companyRecruitingMetastasisUnited States, Australia, Singapore, Spain, Argentina, Chile